Marchex, Inc. (NASDAQ:MCHX - Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 26,512 shares, an increase of 29.9% from the March 15th total of 20,405 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 17,806 shares, the short-interest ratio is presently 1.5 days.
Analyst Ratings Changes
A number of research firms recently weighed in on MCHX. Zacks Research raised shares of Marchex from a "strong sell" rating to a "hold" rating in a report on Thursday, February 12th. Weiss Ratings reissued a "sell (d-)" rating on shares of Marchex in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Marchex currently has an average rating of "Reduce".
Read Our Latest Report on MCHX
Institutional Trading of Marchex
A number of large investors have recently made changes to their positions in the stock. Kanen Wealth Management LLC boosted its stake in shares of Marchex by 10.9% during the fourth quarter. Kanen Wealth Management LLC now owns 1,249,399 shares of the technology company's stock valued at $2,099,000 after purchasing an additional 123,011 shares during the period. XTX Topco Ltd purchased a new stake in Marchex in the fourth quarter worth about $26,000. Marathon Capital Management lifted its stake in Marchex by 13.9% in the third quarter. Marathon Capital Management now owns 61,500 shares of the technology company's stock worth $110,000 after acquiring an additional 7,500 shares during the period. Manatuck Hill Partners LLC purchased a new stake in Marchex in the second quarter worth about $88,000. Finally, Jane Street Group LLC purchased a new stake in Marchex in the first quarter worth about $30,000. 73.46% of the stock is owned by hedge funds and other institutional investors.
Marchex Trading Down 2.9%
Shares of MCHX opened at $1.50 on Thursday. The firm has a market capitalization of $65.87 million, a P/E ratio of -12.50 and a beta of 1.99. Marchex has a 12-month low of $1.26 and a 12-month high of $2.31. The firm has a fifty day moving average price of $1.51 and a 200-day moving average price of $1.63.
Marchex (NASDAQ:MCHX - Get Free Report) last issued its earnings results on Wednesday, March 25th. The technology company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.03). The company had revenue of $10.85 million for the quarter, compared to analysts' expectations of $10.97 million. Marchex had a negative net margin of 11.53% and a negative return on equity of 15.14%. Analysts predict that Marchex will post -0.1 earnings per share for the current year.
Marchex Company Profile
(
Get Free Report)
Marchex, Inc NASDAQ: MCHX operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company's core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.
Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marchex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marchex wasn't on the list.
While Marchex currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.